News
Parsons said the study results "pretty much close the chapter of tenecteplase versus alteplase in the early treatment window for thrombolysis in ischemic stroke (within 4.5 h of symptom onset).
Hosted on MSN11mon
EVT on Large Core Strokes: Sobering Results for the Oldest Old - MSNThe older the patient, the worse the functional outcome tended to be after endovascular thrombectomy (EVT) for an acute ischemic stroke with a large infarct, observational data suggested. Based on ...
“The best outcomes, explains Dr. Modak, “occur when the medication is administered within 3 to 4.5 hours of the onset of ...
Eligible patients had onset of stroke 4.5 to 24 hours before randomization, a posterior circulation Acute Stroke Prognosis Early CT Score (PC-ASPECTS; scores range from 0 to 10, with lower scores ...
PHOENIX -- Endovascular thrombectomy for large-core acute ischemic stroke improved long-term outcomes, the SELECT2 trial affirmed. The intervention shifted the 1-year modified Rankin Scale (mRS ...
Seeking to determine the safety and efficacy of IV tenecteplase compared with alteplase for patients with acute ischemic stroke not eligible for endovascular thrombectomy, researchers conducted a ...
Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of target ...
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.. The approval was supported by data from the registry ...
Similarly, the risk of 90-day mortality (mRS score of 6) was increasingly unfavorable with older age (P<0.001):15.4% at age 60 and below; 31.8% in those 61-70 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results